USD 3.19
↓ -1.49 (-31.84%)
| ticker | 1 day return % | 1 week return % | 1 month return % | 3 months return % | 6 months return % | 1 year return % | 3 years return % | 5 years return % | 10 years return % | maximum return % |
|---|---|---|---|---|---|---|---|---|---|---|
| QMCO | -31.8 | -30.8 | -17.1 | -45.2 | -71.5 | -62.9 | -97.5 | -97.3 | -98.7 | -99.1 |
| S&P 500 | -0.6 | -0.5 | 1.5 | 9.1 | 13.4 | 32.3 | 27.0 | 92.1 | 191.7 | 33587.3 |
Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline
Feel free to experiment with these tools to enhance your technical analysis. Remember, any drawings you make are temporary and will be lost upon refreshing the page unless saved as an image using the 'Camera' icon.
Get instant AI-powered professional insights on prices:
💡Generate AI Technical Analysis ReportA Multi-Interval Candlestick Chart displays the price movements of an asset over different time intervals. Each candlestick represents the open, high, low, and close prices for a specific interval. The chart can be used to identify trends and patterns in price movements.
| Attribute | Value |
|---|---|
| symbol | QMCO |
| name | Quantum Corporation |
| price | 3.19 |
| changes percentage | -31.8376 |
| change | -1.49 |
| day low | 3.19 |
| day high | 4.0001 |
| year high | 18 |
| year low | 2.22 |
| market cap | 15288681 |
| price avg 50 | 3.8484 |
| price avg 200 | 7.60875 |
| exchange | NASDAQ |
| volume | 255992 |
| avg volume | 56825 |
| open | 4 |
| previous close | 4.68 |
| eps | -11 |
| pe | -0.29 |
| earnings announcement | 2024-11-13T05:00:00.000+0000 |
| shares outstanding | 4792690 |
| timestamp | 2024-11-14 21:00:00 |
We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.
| 2024 | 2023 | Y/Y change % | |
|---|---|---|---|
| 0000709283 | |||
| revenue | 311600000 | 412752000 | -24.51 |
| gross profit | 124889000 | 133939000 | -6.76 |
| gross profit ratio | 0.4 | 0.32 | 23.51 |
| research and development expenses | 38046000 | 44555000 | -14.61 |
| operating expenses | 153766000 | 158341000 | -2.89 |
| interest income | 0 | 0 | NaN |
| interest expense | 15089000 | 10560000 | 42.89 |
| ebitda | -16173000 | 4250000 | -480.54 |
| ebitdaratio | -0.05 | -0.03 | -73.78 |
| operating income | -28877000 | -26007000 | -11.04 |
| operating income ratio | -0.09 | -0.06 | -47.08 |
| net income | -41286000 | -37943000 | -8.81 |
| net income ratio | -0.13 | -0.09 | -44.13 |
| eps | -8.68 | -0.42 | -1966.67 |
Revenue Growth: revenue decreased to 312 million in 2024 from 413 million in 2023 representing a change of -24.51%. This indicates a sales shrinking, which is a negative sign for the company.
Gross Profit: Gross Profit decreased to 125 million in 2024 from 134 million in 2023 representing a change of -6.76%. This indicates a sales profitability decline, which is a negative sign for the company.
Research and Development (R&D) Expenses: R&D Expenses decreased to 38 million in 2024 from 45 million in 2023 representing a change of -14.61%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.
EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to -16 million in 2024 from 4 million in 2023 representing a change of -480.54%. The decrease in EBITDA indicates declined operational efficiency and profitability.
Earnings per Share (EPS): EPS increased to -8.68 in 2024 from -8.68 in 2023 representing a change of -1966.67%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.
Operating Expenses: Operating Expenses decreased to 154 million in 2024 from 158 million in 2023 representing a change of -2.89%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.
Operating Income: Operating income increased to -29 million in 2024 from -26 million in 2023 representing a change of -11.04%. The increase in operating income indicates better operational performance and increased profitability.
Net Income: Net income increased to -41 million in 2024 from -38 million in 2023 representing a change of -8.81%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.
| 2025Q2 | 2025Q1 | Q/Q change % | |
|---|---|---|---|
| 0000709283 | |||
| revenue | 70469000 | 71343000 | -1.23 |
| gross profit | 29267000 | 26135000 | 11.98 |
| gross profit ratio | 0.42 | 0.37 | 13.37 |
| research and development expenses | 8264000 | 8308000 | -0.53 |
| operating expenses | 36202000 | 43860000 | -17.46 |
| interest income | 0 | 0 | NaN |
| interest expense | -13711000 | 3790000 | -461.77 |
| ebitda | -6934000 | -15015000 | 53.82 |
| ebitdaratio | -0.1 | -0.21 | 53.25 |
| operating income | -6934000 | -17725000 | 60.88 |
| operating income ratio | -0.1 | -0.25 | 60.39 |
| net income | -13527000 | -20820000 | 35.03 |
| net income ratio | -0.19 | -0.29 | 34.22 |
| eps | -2.82 | -4.34 | 35.02 |
Revenue Growth: revenue decreased to 70 million in 2025Q2 from 71 million in 2025Q1 representing a change of -1.23%. This indicates a sales shrinking, which is a negative sign for the company.
Research and Development (R&D) Expenses: R&D Expenses decreased to 8 million in 2025Q2 from 8 million in 2025Q1 representing a change of -0.53%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.
Net Income: Net income decreased to -14 million in 2025Q2 from -21 million in 2025Q1 representing a change of 35.03%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.
Gross Profit: Gross Profit increased to 29 million in 2025Q2 from 26 million in 2025Q1 representing a change of 11.98%. This indicates a sales profitability growth, which is a positive sign for the company.
Operating Expenses: Operating Expenses decreased to 36 million in 2025Q2 from 44 million in 2025Q1 representing a change of -17.46%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.
EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to -7 million in 2025Q2 from -15 million in 2025Q1 representing a change of 53.82%. The increase in EBITDA indicates improved operational efficiency and profitability.
Operating Income: Operating income increased to -7 million in 2025Q2 from -18 million in 2025Q1 representing a change of 60.88%. The increase in operating income indicates better operational performance and increased profitability.
Earnings per Share (EPS): EPS increased to -2.82 in 2025Q2 from -2.82 in 2025Q1 representing a change of 35.02%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.
| 2024 | 2023 | Y/Y change % | |
|---|---|---|---|
| 0000709283 | |||
| total assets | 187615000 | 213657000 | -12.19 |
| total liabilities | 309113000 | 300545000 | 2.85 |
| total equity | -121498000 | -86888000 | -39.83 |
| cash and cash equivalents | 25692000 | 25963000 | -1.04 |
| short term investments | 0 | 0 | NaN |
| long term investments | 0 | -90300000 | 100.00 |
| total current assets | 131783999 | 153055000 | -13.90 |
| total non current assets | 55831000 | 60602000 | -7.87 |
| total current liabilities | 249944000 | 152596000 | 63.79 |
| total non current liabilities | 59169000 | 147949000 | -60.01 |
| common stock | 959000 | 936000 | 2.46 |
| retained earnings | -827380000 | -808846000 | -2.29 |
| total debt | 119977000 | 99637000 | 20.41 |
Total Assets: Total Assets decreased to 188 million in 2024 from 214 million in 2023 representing a change of -12.19%. Suggesting a decrease in asset holdings.
Total Liabilities: Total Liabilities increased to 309 million in 2024 from 301 million in 2023 representing a change of 2.85%. This indicates an increase in overall liabilities.
Total Equity: Total Equity decreased to -121 million in 2024 from -87 million in 2023 representing a change of -39.83%. This indicates a decrease in shareholders' equity.
Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 26 million in 2024 from 26 million in 2023 representing a change of -1.04%. This indicates a decrease in available liquid assets.
Total Current Assets: Total Current Assets decreased to 132 million in 2024 from 153 million in 2023 representing a change of -13.9%. This indicates a worsen liquidity position.
Total Current Liabilities: Total Current Liabilities increased to 250 million in 2024 from 153 million in 2023 representing a change of 63.79%. This indicates a higher short-term debt burden.
Retained Earnings: Retained Earnings decreased to -827 million in 2024 from -809 million in 2023 representing a change of -2.29%. This indicates an accumulated losses.
Total Debt: Total Debt increased to 120 million in 2024 from 100 million in 2023 representing a change of 20.41%. This indicates an increase in overall debt burden.
Common Stock: Common Stock increased to 1 in 2024 from 1 in 2023 representing a change of 2.46%. This indicates an increase in ownership interest.
| 2025Q2 | 2025Q1 | Q/Q change % | |
|---|---|---|---|
| 0000709283 | |||
| total assets | 163146000 | 173089000 | -5.74 |
| total liabilities | 316549000 | 314340000 | 0.70 |
| total equity | -153403000 | -141251000 | -8.60 |
| cash and cash equivalents | 16719000 | 17287000 | -3.29 |
| short term investments | 0 | 0 | NaN |
| long term investments | 0 | 0 | NaN |
| total current assets | 108853000 | 118732000 | -8.32 |
| total non current assets | 54293000 | 54357000 | -0.12 |
| total current liabilities | 134601000 | 155608000 | -13.50 |
| total non current liabilities | 181948000 | 158732000 | 14.63 |
| common stock | 49000 | 959000 | -94.89 |
| retained earnings | -861727000 | -848200000 | -1.59 |
| total debt | 105691000 | 116747000 | -9.47 |
Total Assets: Total Assets decreased to 163 million in 2025Q2 from 173 million in 2025Q1 representing a change of -5.74%. Suggesting a decrease in asset holdings.
Total Liabilities: Total Liabilities increased to 317 million in 2025Q2 from 314 million in 2025Q1 representing a change of 0.7%. This indicates an increase in overall liabilities.
Total Equity: Total Equity decreased to -153 million in 2025Q2 from -141 million in 2025Q1 representing a change of -8.6%. This indicates a decrease in shareholders' equity.
Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 17 million in 2025Q2 from 17 million in 2025Q1 representing a change of -3.29%. This indicates a decrease in available liquid assets.
Total Current Assets: Total Current Assets decreased to 109 million in 2025Q2 from 119 million in 2025Q1 representing a change of -8.32%. This indicates a worsen liquidity position.
Common Stock: Common Stock decreased to 0 in 2025Q2 from 1 in 2025Q1 representing a change of -94.89%. This indicates a decrease in ownership interest.
Retained Earnings: Retained Earnings decreased to -862 million in 2025Q2 from -848 million in 2025Q1 representing a change of -1.59%. This indicates an accumulated losses.
Total Current Liabilities: Total Current Liabilities decreased to 135 million in 2025Q2 from 156 million in 2025Q1 representing a change of -13.5%. This indicates a lower short-term debt burden.
Total Debt: Total Debt decreased to 106 million in 2025Q2 from 117 million in 2025Q1 representing a change of -9.47%. This indicates a reduction in overall debt burden.
| 2024 | 2023 | Y/Y change % | |
|---|---|---|---|
| 0000709283 | |||
| net change in cash | -315000 | 20682000 | -101.52 |
| operating cash flow | -10156000 | -4894000 | -107.52 |
| free cash flow | -16025000 | -17475000 | 8.30 |
| capital expenditure | -5869000 | -12581000 | 53.35 |
| depreciation and amortization | 9313000 | 10118000 | -7.96 |
| deferred income tax | 0 | 18052000 | -100.00 |
| stock based compensation | 4721000 | 10750000 | -56.08 |
| accounts payables | -11193000 | 1158000 | -1066.58 |
| inventory | 10456000 | -5342000 | 295.73 |
| acquisitions net | 0 | -3020000 | 100.00 |
| investments in property plant and equipment | -5869000 | -12581000 | 53.35 |
| net cash used for investing activites | -5869000 | -15601000 | 62.38 |
| debt repayment | 15713000 | -25981000 | 160.48 |
| common stock issued | 0 | 67146000 | -100.00 |
| common stock repurchased | 0 | 0 | NaN |
| dividends paid | 0 | 0 | NaN |
| net cash used provided by financing activities | 15713000 | 41165000 | -61.83 |
| cash at end of period | 25860000 | 26175000 | -1.20 |
| accounts receivables | 4846000 | -2966000 | 263.39 |
| cash at beginning of period | 26175000 | 5493000 | 376.52 |
Net Change in Cash: Net Change in Cash decreased to 0 million in 2024 from 21 million in 2023 representing a change of -101.52%. Indicating a declined ability to generate cash from the company's operations or its cash flow position.
Operating Cash Flow: Operating Cash Flow decreased to -10 million in 2024 from -5 million in 2023 representing a change of -107.52%. This indicates that the company generated less cash from its core business operations.
Capital Expenditure: Capital Expenditure increased to -6 million in 2024 from -13 million in 2023 representing a change of 53.35%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.
Accounts Payables: The absolute value of Accounts Payables increased to 11 million in 2024 from 1 million in 2023 representing a change of -1066.58%. This indicates that the company has increased its outstanding obligations to its suppliers.
Accounts Receivables: Accounts Receivables increased to 5 in 2024 from -3 million in 2023 representing a change of 263.39%. This suggests that the company is less capable of collecting payments from its customers.
Free Cash Flow: Free Cash Flow increased to -16 million in 2024 from -17 million in 2023 representing a change of 8.3%. This indicates an increase in cash generated after accounting for capital expenditures.
Stock-Based Compensation: Stock-Based Compensation decreased to 5 million in 2024 from 11 million in 2023 representing a change of -56.08%. This indicates decreased expenses, which is generally considered a positive sign from a financial perspective.
| 2025Q2 | 2025Q1 | Q/Q change % | |
|---|---|---|---|
| 0000709283 | |||
| operating cash flow | -15298000 | -1896000 | -706.86 |
| free cash flow | -16906000 | -3516000 | -380.83 |
| capital expenditure | -1608000 | -1620000 | 0.74 |
| depreciation and amortization | 1567000 | 1780000 | -11.97 |
| deferred income tax | 0 | 0 | NaN |
| stock based compensation | 716000 | 925000 | -22.59 |
| accounts receivables | 10292000 | 6346000 | 62.18 |
| accounts payables | -1575000 | 6828000 | -123.07 |
| inventory | -2318000 | 150000 | -1645.33 |
| acquisitions net | 0 | 0 | NaN |
| investments in property plant and equipment | -1608000 | -1620000 | 0.74 |
| net cash used for investing activites | -1608000 | -1620000 | 0.74 |
| debt repayment | 0 | -4798000 | 100.00 |
| common stock issued | 0 | 0 | NaN |
| common stock repurchased | 0 | 0 | NaN |
| dividends paid | 0 | 0 | NaN |
| net cash used provided by financing activities | 16323000 | -4798000 | 440.20 |
| net change in cash | -583000 | -8317000 | 92.99 |
| cash at end of period | 16960000 | 17543000 | -3.32 |
| cash at beginning of period | 17543000 | 25860000 | -32.16 |
Net Change in Cash: Net Change in Cash increased to -1 million in 2025Q2 from -8 million in 2025Q1 representing a change of 92.99%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.
Stock-Based Compensation: Stock-Based Compensation decreased to 1 million in 2025Q2 from 1 million in 2025Q1 representing a change of -22.59%. This indicates decreased expenses, which is generally considered a positive sign from a financial perspective.
Accounts Payables: The absolute value of Accounts Payables decreased to 2 million in 2025Q2 from 7 million in 2025Q1 representing a change of -123.07%. This indicates that the company has reduced its outstanding obligations to its suppliers.
Operating Cash Flow: Operating Cash Flow decreased to -15 million in 2025Q2 from -2 million in 2025Q1 representing a change of -706.86%. This indicates that the company generated less cash from its core business operations.
Free Cash Flow: Free Cash Flow decreased to -17 million in 2025Q2 from -4 million in 2025Q1 representing a change of -380.83%. This indicates a decrease in cash generated after accounting for capital expenditures.
Capital Expenditure: Capital Expenditure increased to -2 million in 2025Q2 from -2 million in 2025Q1 representing a change of 0.74%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.
Accounts Receivables: Accounts Receivables increased to 10 in 2025Q2 from 6 million in 2025Q1 representing a change of 62.18%. This suggests that the company is less capable of collecting payments from its customers.
We save you time by utilizing Generative AI to summarize earnings transcripts. Our summaries provide a clear insight into the company's current performance, future outlook, and overall sentiment expressed during the call. Click on below links to explore more.
Note: The years mentioned below are fiscal years in accounting.
Q2 2025 Earnings call transcript
EPS represents the portion of a company's profit allocated to each outstanding share of common stock. A higher EPS is generally favorable, indicating stronger profitability on a per-share basis.
Positive EPS: A positive EPS signifies that a company is profitable, it is generally viewed positively, supporting stock value and investor confidence.
Negative EPS: Indicates that a company is operating at a loss, which could lead to negative sentiment, potential stock depreciation, and concerns about the company's financial health.
The Next Earning Date represents when the company plans to release its next set of financial results.
An upward trend in EPS suggests consistent growth in earnings, often leading to increased investor confidence. A downward trend may indicate a decline in earnings, potentially decreasing investor confidence and stock value. Fluctuating EPS suggests unpredictable financial performance, warranting cautious investor analysis.
Earnings surprise occurs when a company's actual earnings differ from analysts' expectations. A positive earnings surprise typically reflects better-than-expected performance, potentially leading to stock appreciation. Conversely, a negative earnings surprise can result in stock depreciation. An earnings surprise of zero means the earnings met expectations, which typically has a neutral impact on stock price.
Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.
| 2024-03-31 | 2023-03-31 | Y/Y change % | |
|---|---|---|---|
| FY | |||
| calendar year | 2024 | 2023 | NaN |
| revenue per share | 65.54 | 4.57 | 1334.62 |
| net income per share | -8.68 | -0.42 | -1967.75 |
| operating cash flow per share | -2.14 | -0.05 | -3843.54 |
| free cash flow per share | -3.37 | -0.19 | -1642.64 |
| cash per share | 5.4 | 0.29 | 1780.49 |
| book value per share | -25.56 | -0.96 | -2557.28 |
| tangible book value per share | -28.63 | -1.16 | -2368.58 |
| shareholders equity per share | -25.56 | -0.96 | -2557.28 |
| interest debt per share | 26.12 | 1.09 | 2291.95 |
| market cap | 52868372 | 2078004000 | -97.46 |
| enterprise value | 147153372 | 2151678000 | -93.16 |
| pe ratio | -1.28 | -54.77 | 97.66 |
| price to sales ratio | 0.17 | 5.03 | -96.63 |
| pocfratio | -5.21 | -424.6 | 98.77 |
| pfcf ratio | -3.3 | -118.91 | 97.23 |
| pb ratio | -0.44 | -23.92 | 98.18 |
| ptb ratio | -0.44 | -23.92 | 98.18 |
| ev to sales | 0.47 | 5.21 | -90.94 |
| enterprise value over ebitda | -9.1 | 506.28 | -101.80 |
| ev to operating cash flow | -14.49 | -439.66 | 96.70 |
| ev to free cash flow | -9.18 | -123.13 | 92.54 |
| earnings yield | -0.78 | -0.02 | -4176.83 |
| free cash flow yield | -0.3 | -0.01 | -3504.39 |
| debt to equity | -0.9 | -1.01 | 11.44 |
| debt to assets | 0.58 | 0.41 | 41.02 |
| net debt to ebitda | -5.83 | 17.34 | -133.63 |
| current ratio | 0.53 | 1.0 | -47.43 |
| interest coverage | -1.91 | -2.46 | 22.29 |
| income quality | 0.25 | 0.13 | 90.72 |
| dividend yield | 0 | 0 | NaN |
| payout ratio | 0 | 0 | NaN |
| sales general and administrative to revenue | 0.17 | 0.12 | 42.99 |
| research and ddevelopement to revenue | 0.12 | 0.11 | 13.11 |
| intangibles to total assets | 0.08 | 0.08 | -6.92 |
| capex to operating cash flow | -0.58 | -2.57 | 77.52 |
| capex to revenue | 0.02 | 0.03 | -38.21 |
| capex to depreciation | 0.63 | 1.24 | -49.32 |
| stock based compensation to revenue | 0.02 | 0.03 | -41.83 |
| graham number | 70.66 | 3.01 | 2244.05 |
| roic | 2.37 | -22.54 | 110.51 |
| return on tangible assets | -0.24 | -0.19 | -23.13 |
| graham net net | -46.02 | -2.19 | -2001.54 |
| working capital | -118160001 | 459000 | -25842.92 |
| tangible asset value | -136136000 | -104798000 | -29.90 |
| net current asset value | -177329001 | -147490000 | -20.23 |
| invested capital | -82069001 | 45215000 | -281.51 |
| average receivables | 70126000 | 70909000 | -1.10 |
| average payables | 30901500 | 34968000 | -11.63 |
| average inventory | 36140500 | 51272500 | -29.51 |
| days sales outstanding | 79.41 | 64.08 | 23.91 |
| days payables outstanding | 51.0 | 46.76 | 9.07 |
| days of inventory on hand | 53.83 | 58.58 | -8.10 |
| receivables turnover | 4.6 | 5.7 | -19.30 |
| payables turnover | 7.16 | 7.81 | -8.32 |
| inventory turnover | 6.78 | 6.23 | 8.82 |
| roe | 0.34 | 0.44 | -22.19 |
| capex per share | 1.23 | 0.14 | 786.50 |
ROE: Return on Equity (ROE) decreased to 0.34 on 2024-03-31 from 0.44 on 2023-03-31, representing a change of -22.19%. However, ROE is >= 15%, suggesting that the company has been generating high returns for its shareholders still.
Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to -0.90 on 2024-03-31 from -1.01 on 2023-03-31, representing a change of 11.44%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. Higher leverage may increase financial risk. However, a ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.
PE Ratio: Price-to-Earnings (P/E) Ratio increased to -1.28 on 2024-03-31 from -54.77 on 2023-03-31, representing a change of 97.66%. Indicating an increase in the relative valuation of the company's stock.
Current Ratio: Current Ratio decreased to 0.53 on 2024-03-31 from 1.00 on 2023-03-31, representing a change of -47.43%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. Also, it's below 1, indicating potential liquidity issues.
| 2024-09-30 Q2 | 2024-06-30 Q1 | Q/Q change % | |
|---|---|---|---|
| QMCO | |||
| calendar year | 2025 | 2025 | NaN |
| revenue per share | 14.7 | 14.89 | -1.24 |
| net income per share | -2.82 | -4.34 | 35.04 |
| operating cash flow per share | -3.19 | -0.4 | -706.77 |
| free cash flow per share | -3.53 | -0.73 | -380.78 |
| cash per share | 3.49 | 3.61 | -3.30 |
| book value per share | -32.01 | -29.47 | -8.59 |
| tangible book value per share | -34.87 | -32.43 | -7.51 |
| shareholders equity per share | -32.01 | -29.47 | -8.59 |
| interest debt per share | 19.19 | 22.89 | -16.18 |
| market cap | 16775500 | 37381500 | -55.12 |
| enterprise value | 105747500 | 136841500 | -22.72 |
| pe ratio | -0.31 | -0.45 | 30.93 |
| price to sales ratio | 0.24 | 0.52 | -54.57 |
| pocfratio | -1.1 | -19.72 | 94.44 |
| pfcf ratio | -0.99 | -10.63 | 90.67 |
| pb ratio | -0.11 | -0.26 | 58.68 |
| ptb ratio | -0.11 | -0.26 | 58.68 |
| ev to sales | 1.5 | 1.92 | -21.76 |
| enterprise value over ebitda | -15.25 | -9.11 | -67.34 |
| ev to operating cash flow | -6.91 | -72.17 | 90.42 |
| ev to free cash flow | -6.26 | -38.92 | 83.93 |
| earnings yield | -0.81 | -0.56 | -44.78 |
| free cash flow yield | -1.01 | -0.09 | -971.45 |
| debt to equity | -0.69 | -0.75 | 8.13 |
| debt to assets | 0.65 | 0.61 | 5.85 |
| net debt to ebitda | -12.83 | -6.62 | -93.71 |
| current ratio | 0.81 | 0.76 | 5.99 |
| interest coverage | 0.51 | -4.68 | 110.81 |
| income quality | 1.13 | 0.09 | 1141.87 |
| dividend yield | 0 | 0 | NaN |
| payout ratio | 0 | 0 | NaN |
| sales general and administrative to revenue | 0.2 | 0.3 | -32.83 |
| research and ddevelopement to revenue | 0.12 | 0.12 | 0.70 |
| intangibles to total assets | 0.08 | 0.08 | 2.61 |
| capex to operating cash flow | -0.11 | -0.85 | 87.70 |
| capex to revenue | 0.02 | 0.02 | 0.49 |
| capex to depreciation | 1.03 | 0.91 | 12.75 |
| stock based compensation to revenue | 0.01 | 0.01 | -21.63 |
| graham number | 45.08 | 53.67 | -16.01 |
| roic | 0.15 | 0.51 | -70.56 |
| return on tangible assets | -0.09 | -0.13 | 30.91 |
| graham net net | -52.59 | -49.56 | -6.09 |
| working capital | -25748000 | -36876000 | 30.18 |
| tangible asset value | -167114000 | -155427000 | -7.52 |
| net current asset value | -207696000 | -195608000 | -6.18 |
| invested capital | 8461000 | -2368000 | 457.31 |
| average receivables | 56218500 | 64576000 | -12.94 |
| average payables | 31149000 | 28798000 | 8.16 |
| average inventory | 22972500 | 27258000 | -15.72 |
| days sales outstanding | 65.23 | 77.41 | -15.74 |
| days payables outstanding | 67.25 | 62.73 | 7.22 |
| days of inventory on hand | 41.43 | 53.71 | -22.87 |
| receivables turnover | 1.38 | 1.16 | 18.68 |
| payables turnover | 1.34 | 1.43 | -6.73 |
| inventory turnover | 2.17 | 1.68 | 29.66 |
| roe | 0.09 | 0.15 | -40.18 |
| capex per share | 0.34 | 0.34 | -0.75 |
ROE:
PE Ratio: Price-to-Earnings (P/E) Ratio increased to -0.31 on 2024-09-30 Q2 from -0.45 on 2024-06-30 Q1, representing a change of 30.93%. Indicating an increase in the relative valuation of the company's stock.
Current Ratio: Current Ratio increased to 0.81 on 2024-09-30 Q2 from 0.76 on 2024-06-30 Q1, representing a change of 5.99%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. However, it's below 1, indicating potential liquidity issues.
Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to -0.69 on 2024-09-30 Q2 from -0.75 on 2024-06-30 Q1, representing a change of 8.13%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. Higher leverage may increase financial risk. However, a ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.
None
| Market Capitalization | Enterprise Value | |
|---|---|---|
| Definition | The total market value of a company's outstanding shares | The total market value of a company, including its debt and other liabilities |
| Calculation | Current share price * Total number of outstanding shares | Market capitalization + Total debt - Cash and cash equivalents |
| Focus | Equity component of a company's value | Total economic value of a company |
| Usefulness | Assesses a company's size and growth potential based on investor sentiment | Provides a more comprehensive valuation that considers both equity and debt |
Analyzing dividends is a crucial aspect of investment evaluation, offering valuable insights into a company's financial health and its commitment to shareholder returns. Dividends represent a portion of a company's profits distributed to its shareholders, providing a steady income stream. We help you analyze dividends based on the indicators mentioned below:
• Investors often assess the average dividend amount, observing trends over time to gauge the company's stability and growth potential. A positive trend in average dividends indicates a consistent and potentially lucrative investment. Additionally, evaluating the trend of dividend increases provides insight into the company's financial strength and management's confidence in future earnings.
• Consistency in paying dividends is a reassuring sign, reflecting a company's reliability and commitment to shareholder value. For investors, dividends not only offer income but also contribute to the overall total return on investment.
• Companies with a history of regular and increasing dividends can attract income-focused investors seeking stable returns, making dividends a critical factor in building a well-rounded investment portfolio.
Interested in the overall sentiment for a particular period? Check out our news sentiment analysis tool.
Sentiment: Positive
Publish Date: 2024-11-14 08:00:00
DENVER and HOUSTON, Nov. 14, 2024 (GLOBE NEWSWIRE) -- FourPoint Resources, LLC (“FourPoint”), together with their partners Quantum Capital Group (“Quantum”) and Kayne Anderson, announced today the signing of a purchase and sale agreement to acquire Ovintiv Inc.'s (NYSE, TSX: OVV) Uinta Basin assets for a purchase price of $2.0 billion in cash. The asset includes 126,000 net acres and production of 29 Mbbls/d.
Sentiment: Positive
Publish Date: 2024-11-13 20:41:53
Quantum Corporation (NASDAQ:QMCO ) Q2 2025 Earnings Conference Call November 13, 2024 5:00 PM ET Company Participants Brian Cabrera - Chief Administrative Officer Jamie Lerner - Chairman and Chief Executive Officer Ken Gianella - Chief Financial Officer and Chief Operating Officer Conference Call Participants Eric Martinuzzi - Lake Street Nehal Chokshi - Northland Capital Markets Operator Good afternoon, and welcome to Quantum Corporation's Second Quarter Fiscal 2025 Financial Results Conference Call. At this time, all participants are in listen-only mode.
Sentiment: Positive
Publish Date: 2024-11-13 16:05:00
SAN JOSE, Calif.--(BUSINESS WIRE)--Quantum Corporation (Nasdaq: QMCO) ("Quantum" or the "Company"), a leader in solutions for AI and unstructured data, announced today financial results for its fiscal second quarter 2025 ended September 30, 2024. Fiscal Second Quarter 2025 Financial Summary Revenue was $70.5 million GAAP gross profit was $29.3 million, or 41.5% of revenue GAAP net loss was $13.5 million, or ($2.82) per share Subscription ARR was up 28% year-over-year at $19.6 million Adjusted n.
Sentiment: Positive
Publish Date: 2024-11-13 08:30:00
HOBOKEN, N.J. , Nov. 13, 2024 /PRNewswire/ -- Quantum Computing Inc. ("QCi" or the "Company") (Nasdaq: QUBT), an innovative, integrated photonics and quantum optics technology company, today announced that the Company has secured its first order for its thin film lithium niobate (TFLN) photonic chip foundry.
Sentiment: Positive
Publish Date: 2024-11-13 06:00:00
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that it has been awarded Frost & Sullivan's prestigious 2024 Technology Innovation Leadership Award in North America. This award recognizes QSI's groundbreaking work in developing the Platinum® instrument, the first benchtop sequencer capable of providing single-molecule resolution at the amino acid level, opening new frontiers for.
Sentiment: Positive
Publish Date: 2024-11-12 07:30:00
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced financial results for the third quarter ended September 30, 2024. Press Release Highlights Reported revenue of $787,000 for the third quarter of 2024 Announced that Liberate Bio has integrated Platinum® Next-Generation Sequencing into their platform for developing novel gene therapies with improved targeting capabilities Announced appoi.
Sentiment: Positive
Publish Date: 2024-11-11 09:46:00
Melbourne, Victoria, Australia--(Newsfile Corp. - November 11, 2024) - The Board of Besra Gold Inc. (ASX: BEZ) (Besra or the Company) refers to recent reports regarding a petition for the winding-up by the High Court of Malaysia of Quantum Metal Sdn Bhd (incorporated in Malaysia) (QM Malaysia) that was presented by the Government of Malaysia (Petition). Quantum Metal Recovery Inc (being Besra's largest CDI holder and the contracting party for the Company's Gold Purchase Agreement) has advised Besra that QM Malaysia is a wholly owned subsidiary of Quantum Metal Exchange Inc (incorporated in the USA) and that the Petition exclusively involves QM Malaysia and does not affect in any way Quantum Metal Recovery Inc and Besra.
Sentiment: Neutral
Publish Date: 2024-11-06 16:05:00
HOBOKEN, N.J. , Nov. 6, 2024 /PRNewswire/ -- Quantum Computing Inc.
Sentiment: Neutral
Publish Date: 2024-11-05 09:00:00
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that it will be participating in two upcoming investment conferences. Jeff Hawkins, Quantum-Si's Chief Executive Officer, will participate in a fireside chat discussion at the UBS Global Healthcare Conference on Wednesday, November 13th, at 8:45 AM PT. On Thursday, November 21st at 8:00 AM ET, Mr. Hawkins will participate in a fireside.
Sentiment: Positive
Publish Date: 2024-11-05 02:28:14
First Quantum Minerals shut down its Cobre Panama copper mine last year. The loss of Cobre Panama's production impacted global copper supplies and prices. A restart at Cobre Panama could benefit FQVLF while negatively impacting copper prices.
Sentiment: Positive
Publish Date: 2024-11-02 06:49:28
First Quantum reported a strong Q3, with copper production rising 13% quarter-over-quarter despite Cobre Panama's suspension. Higher grades at Kansanshi and Sentinel reduced C1 cash costs by $0.16, strengthening margins, while gold production surged 20% QoQ, boosting revenue alongside resilient copper prices and record gold prices. Cobre Panama remains a key asset, with ongoing arbitration claims that could unlock significant upside. The market appears to be undervaluing the potential outcomes regarding the Cobre Panama mine closure.
Sentiment: Positive
Publish Date: 2024-10-31 09:41:00
Montreal, Quebec--(Newsfile Corp. - October 31, 2024) - Quantum eMotion Corp. (TSXV: QNC) (OTCQB: QNCCF) ("QeM" or the "Company") proudly announces its feature in the latest column of the Korea Business Herald, one of Asia's most influential business publications. The article, written by Arthur Herman, senior fellow at the Hudson Institute and Director of the Quantum Alliance Initiative, explores how quantum technology can fortify Internet of Things (IoT) security, addressing increasing global concerns about cybersecurity risks in IoT ecosystems.
Sentiment: Negative
Publish Date: 2024-10-31 08:30:00
By integrating Riverlane's quantum error decoder into the control system of Rigetti's 84-qubit Ankaa™-2 system, the team was able to demonstrate real-time, low latency quantum error correction, a critical process for developing fault tolerant quantum computers By integrating Riverlane's quantum error decoder into the control system of Rigetti's 84-qubit Ankaa™-2 system, the team was able to demonstrate real-time, low latency quantum error correction, a critical process for developing fault tolerant quantum computers
Sentiment: Positive
Publish Date: 2024-10-31 06:00:00
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that the Company will host an Investor & Analyst event in New York City on November 20th, 2024. Quantum-Si's management team will provide updates on the Company's evolving technology roadmap, emerging applications for protein sequencing and the expanding commercial opportunities that these innovations create. A live question and ans.
Sentiment: Neutral
Publish Date: 2024-10-30 16:05:00
The UK's National Quantum Computing Centre (NQCC) officially opened the doors of its landmark facility on Harwell Campus on October 25. The state-of-the-art facility includes a fully operational 24-qubit Ankaa ™ -class Rigetti system, which will be made available to NQCC researchers for testing, benchmarking, and exploratory applications development.
Sentiment: Positive
Publish Date: 2024-10-30 09:10:00
BETHESDA, Md.--(BUSINESS WIRE)--Quantum Xchange today announced that its crypto-agile, PQC management platform, Phio TX™ has achieved FIPS 140-3 certification, meeting the rigorous security requirements for cryptographic modules used by the U.S. Government, its agency partners, and commercial businesses. Federal Information Processing Standard (FIPS) 140-3, published by the National Institute of Standards and Technology (NIST), is the U.S. government standard used in designing and implementing.
Sentiment: Positive
Publish Date: 2024-10-30 08:30:00
HOBOKEN, N.J. , Oct. 30, 2024 /PRNewswire/ -- Quantum Computing Inc. ("QCi" or the "Company") (Nasdaq: QUBT), an innovative, integrated photonics and quantum optics technology company, is pleased to announce significant progress as it approaches the final commissioning of its quantum photonic chip foundry, set to open in Q1 2025.
Sentiment: Positive
Publish Date: 2024-10-30 06:00:00
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced its attendance at the 2024 American Society of Human Genetics (ASHG) Annual Meeting, where it will host a sponsored talk on the role of Next-Generation Protein Sequencing (NGPS) in advancing genomics research. The presentation, titled “From Prediction to Protein: Validating Transcriptomics Data with Quantum-Si's Next-Generation Protein.
Sentiment: Positive
Publish Date: 2024-10-29 07:30:00
TORONTO, ON / ACCESSWIRE / October 29, 2024 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, today announces through its subsidiary, HUGE Biopharma Australia Pty Ltd.
Sentiment: Neutral
Publish Date: 2024-10-28 11:10:00
HOUSTON , Oct. 28, 2024 /PRNewswire/ -- On Sunday, Christian Attar ("CA"), with co-counsel Freedman Normand Friedland, filed a market manipulation case on behalf of a firm client, Quantum Biopharma Ltd. (Nasdaq: QNTM) (CSE: QNTM), against CIBC World Markets, Inc. ("CIBC"), RBC Dominion Securities Inc. ("RBC"), and others.
* The sentiment analysis presented is generated through an algorithm and may be subject to inaccuracies. Users are advised to corroborate key information and employ further analytical methods prior to making critical decisions.
Get instant AI-powered professional insights:
💡Generate AI Technical Analysis ReportUnderstand the chart below:
Interpret Technical Indicators
| Indicator | Bullish | Bearish |
|---|---|---|
| Price and EMA ⓘ | Price crosses above EMA | Price crosses below EMA |
| Short-Term vs Long-Term EMA ⓘ | Short EMA crosses above Long EMA | Short EMA crosses below Long EMA |
| Volume ⓘ | Increasing volume during price uptrend | Increasing volume during price downtrend |
| MACD ⓘ | MACD crosses above Signal Line | MACD crosses below Signal Line |
| RSI ⓘ | RSI is below 30 (oversold) and starts to rise above 30 | RSI is above 70 (overbought) and starts to decline below 70 |
| Candlestick Patterns ⓘ | Bullish candlestick patterns | Bearish candlestick patterns |
Copyright © 2024 Sirius Investors
All rights reserved
